Blocking IL-11 protein extends mice lifespan by 25%, boosts muscle mass, hair, and reduces tumors, as per a Nature study. Conducted by Duke-NUS and Imperial College researchers Widjaja and Cook, it shows promise for humans. Russia and the UK advance cancer vaccine trials. WHO highlights global cancer risk, with 1 in 5 affected.